Cerba Research grows in their global reach to support drug development
Cerba Research (Ghent, Belgium), a prominent global provider of clinical trial laboratory services, is widening its scope and evolving into a multi-specialist and central laboratory company. This transformation aims to enhance research organizations’ access to outstanding scientific and technical teams across various therapeutic horizons, facilitating advancements in drug and vaccine development.
By acquiring Viroclinics-DDL, a leading global expert in virology and immunology, and Cirion Biopharma Research, a Canada-based integrated bioanalytical and global central laboratory services provider, Cerba Research deepens its expertise in the biotech field and aims to expand its global presence. This strategic move now enables biotech and pharmaceutical companies, Contract Research Organizations (CROs), and Non-Governmental Organizations (NGOs) to collaborate with a single partner for all their testing needs.
Operating a global network comprising of over 1000 laboratories and drawing from data sourced from over 85 million patients across five continents, Cerba Research stands at the forefront of several therapeutic areas including: oncology, rare disease, and infectious disease research. Cerba Research has a long list of recent achievements, having played a pivotal role in the development of three CAR-T+ therapy drugs that received regulatory approval, contributed significantly to the creation of authorized COVID vaccines, coupled participating in government task forces addressing the SARS-CoV-2 pandemic in both the United States and Europe.
Cerba Research dedicates themselves to realizing the potential of precision and predictive medicine, with the aim to improve people’s well-being. Their commitment to revolutionizing research and advancing healthcare starts with their recent transformation into a central and multi-specialty laboratory provider.
“No other provider can deliver such a range of specialist testing techniques with such flexibility at such scale. But while excellence is a fundamental value at Cerba Research, the daily motivation starts with the patient,” explained Douglas Cookson, Chief Marketing Officer at Cerba Research.
